A Protective, Single-Visit TB Vaccination Regimen by Co-Administration of a Subunit Vaccine with BCG

A single dose of an expression-optimized version of a H107 vaccine candidate/CAF®01 adjuvant with Bacillus Calmette-Guérin (BCG) induced long-lived immunity and triggered BCG-specific T helper 17 cell responses.